Sudhanshu Mulay, MD
Adjunct Assistant ProfessorDownloadHi-Res Photo
About
Titles
Adjunct Assistant Professor
Biography
Dr. Mulay received his medical degree from BJ Medical College, Pune, India. He completed his internal medicine residencies at Michael Reese Hospital, Chicago, Illinois, as well as the University of Connecticut School of Medicine, Farmington.
Dr. Mulay also completed two fellowships; one in hematology/oncology at the University of Connecticut School of Medicine, and one in transfusion medicine at the Mayo Clinic, Rochester, Minnesota.
Dr. Mulay holds memberships at the American Society of Clinical Oncology, the American Society of Hematology, and the International Society on Thrombosis and Haemostasis.
Appointments
Medical Oncology
Assistant Professor AdjunctPrimary
Other Departments & Organizations
Education & Training
- MD
- BJ Medical College (2004)
Research
Clinical Trials
Current Trials
Phase 2 Study of Pembrolizumab and Brentuximab Vedotin in Subjects With Relapsed/Refractory CD30 Positive T-cell Lymphoma
HIC ID2000029793RoleSub InvestigatorPrimary Completion Date04/30/2028Recruiting ParticipantsA Phase 3, Randomized, Multicenter, Double-Blind, Placebo-Controlled, Efficacy and Safety Study of Birtamimab Plus Standard of Care vs. Placebo Plus Standard of Care in Mayo Stage IV Subjects With Light Chain (AL) Amyloidosis
HIC ID2000030933RoleSub InvestigatorPrimary Completion Date06/30/2024Recruiting ParticipantsA Randomized, Phase IIB, Multicenter, Trial of Oral Azacytidine Plus Romidepsin Versus Investigator's Choice in Patients With Relapse or Refractory Peripheral T-cell Lymphoma (PTCL)
HIC ID2000030190RoleSub InvestigatorPrimary Completion Date06/02/2026Recruiting ParticipantsNovel Combination of Belantamab Mafodotin and Elotuzumab to Enhance Therapeutic Efficacy in Multiple Myeloma
HIC ID2000028918RoleSub InvestigatorPrimary Completion Date01/01/2025Recruiting ParticipantsEffective Quadruplet Utilization After Treatment Evaluation (EQUATE): A Randomized Phase 3 Trial for Newly Diagnosed Multiple Myeloma Not Intended for Early Autologous Transplantation
HIC ID2000029969RoleSub InvestigatorPrimary Completion Date12/31/2027Recruiting Participants